Stocks in the $10-50 range offer a sweet spot between affordability and stability as they’re typically more established than penny stocks. But their headline prices don’t guarantee quality, and investors should exercise caution as some have shaky business models. These dynamics can cause headaches for even the most seasoned professionals, which is why we started StockStory - to help you separate the good companies from the bad. Keeping that in mind, here are three stocks under $50 to avoid and some other investments you should consider instead. Chewy (CHWY) Share Price: $38.05 Founded by Ryan Cohen, who later became known for his involvement in GameStop, Chewy (NYSE:CHWY) is an online retailer specializing in pet food, supplies, and healthcare services. Why Does CHWY Fall Short? Annual sales growth of 9.8% over the last three years lagged behind its consumer internet peers as its large revenue base made it difficult to generate incremental demand Estimated sales growth of 4.5% for the next 12 months implies demand will slow from its three-year trend Gross margin of 28.8% reflects its high servicing costs At $38.05 per share, Chewy trades at 24.1x forward EV/EBITDA. Check out our free in-depth research report to learn more about why CHWY doesn’t pass our bar. Zurn Elkay (ZWS) Share Price: $34.28 Claiming to have saved more than 30 billion gallons of water, Zurn Elkay (NYSE:ZWS) provides water management solutions to various industries. Why Does ZWS Worry Us? Core business is underperforming as its organic revenue has disappointed over the past two years, suggesting it might need acquisitions to stimulate growth Estimated sales growth of 3.5% for the next 12 months implies demand will slow from its two-year trend Issuance of new shares over the last five years caused its earnings per share to fall by 8.2% annually, even worse than its revenue declines Zurn Elkay’s stock price of $34.28 implies a valuation ratio of 25.2x forward P/E. To fully understand why you should be careful with ZWS, check out our full research report (it’s free). IMAX (IMAX) Share Price: $25.03 Originally developed for World Expo '67 in Montreal as an innovative projection system, IMAX (NYSE:IMAX) provides proprietary large-format cinema technology and systems that deliver immersive movie experiences with enhanced image quality and sound. Why Are We Wary of IMAX? Products and services are facing end-market challenges during this cycle, as seen in its flat sales over the last five years Cash-burning history makes us doubt the long-term viability of its business model Negative returns on capital show management lost money while trying to expand the business Story Continues IMAX is trading at $25.03 per share, or 20x forward P/E. Dive into our free research report to see why there are better opportunities than IMAX. Stocks That Overcame Trump’s 2018 Tariffs Donald Trump’s victory in the 2024 U.S. Presidential Election sent major indices to all-time highs, but stocks have retraced as investors debate the health of the economy and the potential impact of tariffs. While this leaves much uncertainty around 2025, a few companies are poised for long-term gains regardless of the political or macroeconomic climate, like our Top 5 Strong Momentum Stocks for this week. This is a curated list of our High Quality stocks that have generated a market-beating return of 175% over the last five years. Stocks that made our list in 2019 include now familiar names such as Nvidia (+2,183% between December 2019 and December 2024) as well as under-the-radar businesses like United Rentals (+322% five-year return). Find your next big winner with StockStory today for free. View Comments
3 Stocks Under $50 with Questionable Fundamentals
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...